283 related articles for article (PubMed ID: 36675000)
1. Assessing the Role of Aquaporin 4 in Skeletal Muscle Function.
Aslesh T; Al-Aghbari A; Yokota T
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675000
[TBL] [Abstract][Full Text] [Related]
2. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
[TBL] [Abstract][Full Text] [Related]
3. Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies.
Assereto S; Mastrototaro M; Stringara S; Gazzerro E; Broda P; Nicchia GP; Svelto M; Bruno C; Nigro V; Lisanti MP; Frigeri A; Minetti C
Cell Cycle; 2008 Jul; 7(14):2199-207. PubMed ID: 18641458
[TBL] [Abstract][Full Text] [Related]
4. Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4.
Frigeri A; Nicchia GP; Balena R; Nico B; Svelto M
FASEB J; 2004 May; 18(7):905-7. PubMed ID: 15033928
[TBL] [Abstract][Full Text] [Related]
5. Altered aquaporin-4 expression in human muscular dystrophies: a common feature?
Frigeri A; Nicchia GP; Repetto S; Bado M; Minetti C; Svelto M
FASEB J; 2002 Jul; 16(9):1120-2. PubMed ID: 12039847
[TBL] [Abstract][Full Text] [Related]
6. Characterization of aquaporin-4 in muscle and muscular dystrophy.
Crosbie RH; Dovico SA; Flanagan JD; Chamberlain JS; Ownby CL; Campbell KP
FASEB J; 2002 Jul; 16(9):943-9. PubMed ID: 12087055
[TBL] [Abstract][Full Text] [Related]
7. Reduced aquaporin 4 expression in the muscle plasma membrane of patients with Duchenne muscular dystrophy.
Wakayama Y; Jimi T; Inoue M; Kojima H; Murahashi M; Kumagai T; Yamashita S; Hara H; Shibuya S
Arch Neurol; 2002 Mar; 59(3):431-7. PubMed ID: 11890849
[TBL] [Abstract][Full Text] [Related]
8. Aquaporin 4 mRNA levels in neuromuscular tissues of wild-type and dystrophin-deficient mice.
Shibuya S; Hara H; Wakayama Y; Inoue M; Jimi T; Matsuzaki Y
Tohoku J Exp Med; 2008 Aug; 215(4):313-9. PubMed ID: 18679005
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle function and water permeability in aquaporin-4 deficient mice.
Yang B; Verbavatz JM; Song Y; Vetrivel L; Manley G; Kao WM; Ma T; Verkman AS
Am J Physiol Cell Physiol; 2000 Jun; 278(6):C1108-15. PubMed ID: 10837338
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
11. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
[TBL] [Abstract][Full Text] [Related]
12. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
[TBL] [Abstract][Full Text] [Related]
13. Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice.
Tamma R; Annese T; Capogrosso RF; Cozzoli A; Benagiano V; Sblendorio V; Ruggieri S; Crivellato E; Specchia G; Ribatti D; De Luca A; Nico B
Lab Invest; 2013 May; 93(5):592-610. PubMed ID: 23528847
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
15. Altered aquaporin 4 expression in muscles of Fukuyama-type congenital muscular dystrophy.
Wakayama Y; Jimi T; Inoue M; Kojima H; Yamashita S; Kumagai T; Murahashi M; Hara H; Shibuya S
Virchows Arch; 2003 Dec; 443(6):761-7. PubMed ID: 12942324
[TBL] [Abstract][Full Text] [Related]
16. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
[TBL] [Abstract][Full Text] [Related]
17. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of aquaporin 4 in human muscles with amyotrophic lateral sclerosis and other neurogenic atrophies.
Jimi T; Wakayama Y; Matsuzaki Y; Hara H; Inoue M; Shibuya S
Pathol Res Pract; 2004; 200(3):203-9. PubMed ID: 15200272
[TBL] [Abstract][Full Text] [Related]
19. Dysbindin, syncoilin, and beta-synemin mRNA levels in dystrophic muscles.
Wakayama Y; Matsuzaki Y; Yamashita S; Inoue M; Jimi T; Hara H; Unaki A; Iijima S; Masaki H
Int J Neurosci; 2010 Feb; 120(2):144-9. PubMed ID: 20199207
[TBL] [Abstract][Full Text] [Related]
20. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
